Ventilation-perfusion ratios and V/Q mismatch

Last updated: June 19, 2025

Ventilation-perfusion ratios and V/Q mismatch

Cardiothoracic Disease

Cardiothoracic Disease

Respiratory system anatomy and physiology
Lung volumes and capacities
Anatomic and physiologic dead space
Ventilation
Alveolar gas equation
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Alveolar surface tension and surfactant
Airflow, pressure, and resistance
Breathing cycle
Breathing control
Pulmonary chemoreceptors and mechanoreceptors
Ideal (general) gas law
Boyle's law
Dalton's law
Henry's law
Fick's laws of diffusion
Graham's law
Diffusion-limited and perfusion-limited gas exchange
Hypoxia
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Erythropoietin
Carbon dioxide transport in blood
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Pulmonary changes during exercise
Pulmonary changes at high altitude and altitude sickness
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Restrictive lung diseases
Idiopathic pulmonary fibrosis
Sarcoidosis
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Mesothelioma
Cardiovascular system anatomy and physiology
Lymphatic system anatomy and physiology
Cardiac cycle
Normal heart sounds
Abnormal heart sounds
Blood pressure, blood flow, and resistance
Resistance to blood flow
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Cardiovascular changes during hemorrhage
Cardiovascular changes during postural change
Measuring cardiac output (Fick principle)
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac conduction velocity
Excitability and refractory periods
Cardiac excitation-contraction coupling
Cardiac contractility
Cerebral circulation
Coronary circulation
Control of blood flow circulation
Microcirculation and Starling forces
Cardiomyopathies: Clinical
Cardiomyopathies: Pathology review
Hypertrophic cardiomyopathy
Dilated cardiomyopathy
Restrictive cardiomyopathy
Sleep apnea
Apnea of prematurity
Aortic aneurysms and dissections: Clinical
Aortic dissections and aneurysms: Pathology review
Aortic dissection
Aneurysms
Marfan syndrome
Peripheral vascular disease: Clinical
Peripheral artery disease: Pathology review
Peripheral artery disease
Arterial disease
Deep vein thrombosis
Leg ulcers: Clinical
Chronic venous insufficiency
Thrombophlebitis
Vasculitis: Pathology review
Vasculitis
Kawasaki disease
Behcet's disease
Nutcracker syndrome
Superior mesenteric artery syndrome
Subclavian steal syndrome
Coronary steal syndrome
Lymphedema
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG intervals
ECG axis
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Heart blocks: Pathology review
Premature ventricular contraction
Premature atrial contraction
Atrial fibrillation
Atrial flutter
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Atrioventricular block
Bundle branch block
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Brugada syndrome
Ventricular fibrillation
Pulseless electrical activity
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Positive inotropic medications
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Presynaptic
cGMP mediated smooth muscle vasodilators
Calcium channel blockers
Heart failure: Clinical
Heart failure: Pathology review
Heart failure
Cor pulmonale
Pulmonary hypertension
Pulmonary edema
Anatomy of the coronary circulation
Asthma: Clinical
Obstructive lung diseases: Pathology review
Asthma
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic bronchitis
Emphysema
Alpha 1-antitrypsin deficiency
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Non-corticosteroid immunosuppressants and immunotherapies
Cystic fibrosis: Pathology review
Cystic fibrosis
Bronchiectasis
Anatomy of the heart
Anatomy clinical correlates: Heart
Cardiac muscle histology
Marfan syndrome
Ehlers-Danlos syndrome
Arteriole, venule and capillary histology
Cardiac muscle histology
Artery and vein histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Nasal cavity and larynx histology
Coarctation of the aorta
Mitral valve disease
Pulmonary valve disease
Tricuspid valve disease
Aortic valve disease
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Coronary artery disease: Clinical
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Coronary steal syndrome

Transcript

Watch video only

Alveolar ventilation (V) is the amount of air that reaches alveoli in the lungs, measured in liters/minute (L/min); and perfusion (Q) is the pulmonary blood flow, or cardiac output, that reaches the arteries, and specifically the capillaries, surrounding the alveoli, also measured in L/min.

When the lungs are upright and at rest, ventilation is about 4 L/min and perfusion is about 5 L/min, giving a ratio of 0.8.

Now, the lungs can be divided into three distinct zones.

Zone 1 is the top of the lungs, or the apexes; zone 2 is the middle of the lungs; and zone 3 is the bottom, or bases, of the lungs.

In an upright position, gravity dramatically affects both ventilation and perfusion across all three zones, and overall the V/Q ratio progressively decreases from zone 1 to zone 2 and finally to zone 3.

In zone 1, the flow of air and blood is the lowest with ventilation of around 0.25 L/min, and perfusion of around 0.07 L/min; generating a V/Q ratio of 3.6.

In zone 2, ventilation is equal to perfusion; generating a V/Q ratio of about 1.

In zone 3, the flow of air and blood is the highest with ventilation of around 0.8 L/min, and perfusion of around 1.3 L/min; generating a V/Q ratio of 0.6.

So the V/Q ratio varies depending on which part of the lung is involved, but the overall ratio is an average of the three zones and works out to be 0.8.

Now, the ratio of V to Q influences how efficiently gases, specifically O2 and CO2 , are exchanged in the lungs.

In healthy lungs with a V/Q ratio of 0.8, the alveolar partial pressure of O2 (PAO2), is about 100 mmHg or millimeters of mercury; and the alveolar partial pressure of CO2 (PACO2) is about 40 mmHg.

Meanwhile, the arterial partial pressure of O2 (PaO2) is around 95 mmHg - slightly lower than what’s on the alveolar side; and the arterial partial pressure of CO2 (PaCO2) is about 40 mmHg - the same as what’s on the alveolar side.

But these partial pressures are also an average over the the three lung zones.

In zone 1 the arterial partial pressure of O2 (PaO2) is 130 mmHg and arterial partial pressure of CO2 (PaCO2) is 28 mmHg.

In Zone 2 the arterial partial pressure of O2 (PaO2) is about 108 mmHg and arterial partial pressure of CO2 (PaCO2) is about 39 mmHg.

And in zone 3, the arterial partial pressure of O2 (PaO2) is 88 mmHg and arterial partial pressure of CO2 (PaCO2) is 42 mmHg.

So, a drop of blood in zone 1 gets more oxygen diffused into it than a drop of blood in zone 3, but because zone 3 has about 19 times more blood flowing through per minute, it ends up accounting for more of the overall gas exchange.

Key Takeaways

Ventilation-perfusion (V/Q) ratio is a measure of the relationship between the amount of air entering the alveoli (V) and the amount of blood flowing through the capillaries surrounding the alveoli in the lungs (Q). V/Q mismatch is a condition that occurs when this ratio is not properly matched resulting in ventilation-perfusion mismatch or dead space ventilation. V/Q mismatch can be caused by various factors, such as lung conditions like pulmonary embolism, asthma, COPD, and interstitial lung diseases.

Sources

  1. "Medical Physiology" Elsevier (2016)
  2. "Physiology" Elsevier (2017)
  3. "Human Anatomy & Physiology" Pearson (2018)
  4. "Principles of Anatomy and Physiology" Wiley (2014)
  5. "Physiologic Factors Influencing the Arterial-To-End-Tidal CO2 Difference and the Alveolar Dead Space Fraction in Spontaneously Breathing Anesthetised Horses" Frontiers in Veterinary Science (2018)
  6. "Detection of Lung Dysfunction Using Ventilation and Perfusion SPECT in a Mouse Model of Chronic Cigarette Smoke Exposure" Journal of Nuclear Medicine (2013)